LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of ‘sunset glow fundus’ in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada disease

Photo from wikipedia

To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first‐line therapy combined with systemic corticosteroids in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease. Click to show full abstract

To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first‐line therapy combined with systemic corticosteroids in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease.

Keywords: systemic corticosteroids; onset acute; initial onset; combined systemic; acute uveitis; mycophenolate mofetil

Journal Title: Acta Ophthalmologica
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.